Needham & Company raised its price target and gave an 'outperform' rating for Steven Madden, Ltd., whose stock is listed on the Nasdaq exchange.
3 reports, 1 independent
Updated Sep 22
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company raised its price target and gave an 'outperform' rating for Steven Madden, Ltd., whose stock is listed on the Nasdaq exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Needham & Company and Cantor Fitzgerald raised price objectives and issued buy ratings for Annexon, with MarketBeat reporting consensus data.
- Needham & Company cut its target price and set a buy rating for Applied Optoelectronics, while Raymond James Financial reiterated an outperform rating. MarketBeat provided consensus data.
- Citigroup reissued a market outperform rating and Needham lifted its target price for Alkami Technology Inc.
- Needham & Company downgraded Heron Therapeutics stock rating, while MarketBeat provided average stock rating data.
- Analyst firms Needham & Company, William Blair, and Scotiabank reviewed N-able, Inc., with rating and price target adjustments made on May 27, 2026.